Recent Updates
Recently added Catalysts
AKBA Positive Sentiment

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...

Thursday, May 23, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Akebia Therapeutics, a biopharmaceutical company focused on kidney disease, announced that CEO John Butler will present at the Jefferies Global Healthcare Conference on June 5, 2024. The conference will be held in New York from June 4-6, 2024. A webcast of the presentation will be available for 30 days on Akebia's website.
Price reaction · baseline $1.1 (2024-05-22 close) · hit after-hours · clean, no other AKBA news in the window
day 0 close
-0.9%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Akebia is actively engaging with the healthcare community.
  • The presentation at a prominent conference highlights their commitment.
  • The company aims to improve the lives of those with kidney disease.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+1%
120-day peak, hindsight
Typical move
8%
average across 4 past catalysts
Lead asset
ferric
Phase 3 · Anemia of Chronic Kidney Disease

Full Press Release Details

CAMBRIDGE, Mass. , May 23, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA ), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler , Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 9:00 a.m. ET .
The Jefferies Global Healthcare Conference will take place in New York, NY on June 4-6, 2024 .
A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.
About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts . For more information, please visit our website at www.akebia.com , which does not form a part of this release.
Akebia Therapeutics Contact Mercedes Carrasco [email protected]

Frequently Asked Questions

When will Akebia present at the Jefferies Conference?

Akebia will present on June 5, 2024, at 9:00 a.m. ET.

Where is the Jefferies Global Healthcare Conference held?

The conference will take place in New York, NY from June 4-6, 2024.

How can I access the presentation webcast?

The webcast will be available on Akebia's website for 30 days after the conference.

What is the focus of Akebia Therapeutics?

Akebia Therapeutics aims to improve the lives of people impacted by kidney disease.

ShareAdd on Google
Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics kidney disease Jefferies Global Healthcare Conference John Butler biopharmaceutical
Last updated: May 23, 2024

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$156M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ferricPhase 3
Anemia of Chronic Kidney Disease →

Catalyst track record

+1%
best trade around AKBA's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for AKBA.

See every catalyst's timing & PoA →